Equillium Inc at Rodman & Renshaw Global Investment Conference Sponsored by H C Wainwright Transcript
Hello, again. Our next presenter is Bruce Steel, who is the Co-Founder, Director, President, and CEO of Equillium, Inc. Equillium is focused on developing drugs to address unmet needs in immunoinflammatory disorders. Please join me in welcoming Bruce.
Good morning, Boobalan, and thank you very much. I'm very pleased to present Equillium to you this morning. I hope everybody is doing well despite the ongoing pandemic. A quick slide of our forward-looking statements.
I'm very pleased to provide some updates today. We actually had a press release this morning that I'll cover here in a moment. But in terms of an introduction for those of you who are new to the Equillium story, we aspire to build a world-class biotechnology company focused on improving the lives of patients suffering from severe immunoinflammatory disorders. We are developing itolizumab, EQ001, which is a first-in-class antibody therapeutic for the treatment of a range of autoimmune and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |